NEONATAL CONDITIONS
A practical guide for SCN clinical staff · Congenital hypothyroidism and neonatal thyroid dysfunction - a preventable cause of intellectual disability
Thyroid hormone is essential for brain development. The fetus relies on maternal T4 across the placenta early on, while the fetal gland and hypothalamic-pituitary-thyroid axis mature through the second and third trimesters.
The thyroid traps iodide and uses thyroid peroxidase to build T4 (and some T3); pituitary TSH drives the gland, under negative feedback from circulating thyroid hormone.
Most cases are thyroid dysgenesis - an absent, hypoplastic or ectopic gland. A minority are dyshormonogenesis (an enzyme defect such as TPO), which is often inherited and can cause a goitre.
Primary CH gives a low T4 with a high TSH - the basis of screening. Central (hypothalamic-pituitary) CH gives a low T4 with a low or normal TSH, so TSH-based screening misses it.
A raised heel-prick TSH flags primary CH before any symptoms, because maternal T4 masks the deficiency in the first days of life.
As maternal hormone clears, features appear - prolonged jaundice, poor feeding, constipation, hypotonia, a large fontanelle - and untreated CH causes irreversible intellectual disability.
Maternal Graves TRAb crosses the placenta and can cause transient neonatal thyrotoxicosis; blocking antibodies or antithyroid drugs cause transient hypothyroidism. Preterm or sick infants may have transiently abnormal TFTs.
Catch it on newborn screening, start levothyroxine promptly without waiting for imaging, and involve paediatric endocrinology.
Why does newborn screening use TSH, and what does it miss?
Why must levothyroxine start before confirmatory imaging in congenital hypothyroidism?
How does maternal thyroid disease affect the baby, in both directions?
What are the long-term consequences of delayed treatment?
Take-home message: Congenital hypothyroidism is one of the few preventable causes of intellectual disability, caught by newborn screening (TSH) before symptoms appear. Start levothyroxine promptly - within the first two weeks and before imaging - and refer to endocrinology. Remember that central hypothyroidism can be missed by screening, and maternal Graves disease can cause transient neonatal thyrotoxicosis.
For educational purposes only. Always align management to current ANZCOR/NRP guidelines and your local SCN/NICU or NETS protocols.